Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
14.51
-0.24 (-1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
March 28, 2025
FDA sets PDUFA goal date of May 24, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Breaking Down Liquidia: 4 Analysts Share Their Views
January 09, 2025
Via
Benzinga
The Analyst Landscape: 11 Takes On Liquidia
November 14, 2024
Via
Benzinga
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
March 27, 2025
From
Liquidia Corporation
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About Liquidia
March 20, 2025
Via
Benzinga
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
March 20, 2025
Via
Benzinga
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
March 19, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
Uncovering Potential: Liquidia's Earnings Preview
November 12, 2024
Via
Benzinga
Evaluating Liquidia: Insights From 14 Financial Analysts
October 03, 2024
Via
Benzinga
Earnings Scheduled For March 19, 2025
March 19, 2025
Via
Benzinga
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
March 18, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
March 12, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
February 24, 2025
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025
From
Liquidia Corporation
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
December 26, 2024
Via
Benzinga
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia to Present at the Stifel 2024 Healthcare Conference
November 12, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
November 06, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
November 04, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
October 07, 2024
Via
Benzinga
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
October 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
October 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm
September 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
September 30, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm
September 16, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
September 16, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
September 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.